Related references
Note: Only part of the references are listed.NOTCH1 extracellular juxtamembrane expansion mutations in T-ALL
Maria Luisa Sulis et al.
BLOOD (2008)
FBXW7 mutation in adult T-cell and B-cell acute lymphocytic leukemias
Jee Hoon Song et al.
LEUKEMIA RESEARCH (2008)
In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993)
Anthony H. Goldstone et al.
BLOOD (2008)
Notch-1 mutations are secondary events in some patients with T-Cell acute lymphoblastic leukemia
Marc R. Mansour et al.
CLINICAL CANCER RESEARCH (2007)
Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia
Teresa Palomero et al.
NATURE MEDICINE (2007)
FLT3 tyrosine kinase domain mutations are biologically distinct from and have a significantly more favorable prognosis than FLT3 internal tandem duplications in patients with acute myeloid leukemia
Adam J. Mead et al.
BLOOD (2007)
FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to γ-secretase inhibitors
Jennifer O'Neil et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia
Benjamin J. Thompson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Notch signals positively regulate activity of the mTOR pathway in T-cell acute lymphoblastic leukemia
Steven M. Chan et al.
BLOOD (2007)
Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers
Richard S. Maser et al.
NATURE (2007)
The tumor suppressor gene hCDC4 is frequently mutated in human T-cell acute lymphoblastic leukemia with functional consequences for Notch signaling
Alena Malyukova et al.
CANCER RESEARCH (2007)
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial
Anthony V. Moorman et al.
BLOOD (2007)
Molecular relapse in adult standard-risk ALL patients detected by prospective MRD monitoring during and after maintenance treatment:: data from the GMALL 06/99 and 07/03 trials
Thorsten Raff et al.
BLOOD (2007)
Targeting the NF-kappa B signaling pathway in Notch1-induced T-cell leukemia
Tomas Vilimas et al.
NATURE MEDICINE (2007)
NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth
Teresa Palomero et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia
Stephen Breit et al.
BLOOD (2006)
c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma
Andrew P. Weng et al.
GENES & DEVELOPMENT (2006)
NOTCH1 mutations in T-cell acute lymphoblastic leukemia:: Prognostic significance and implication in multifactorial leukemogenesis
Yong-Mei Zhu et al.
CLINICAL CANCER RESEARCH (2006)
High incidence of Notch-1 mutations in adult patients with T-cell acute lymphoblastic leukemia
MR Mansour et al.
LEUKEMIA (2006)
Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia
M Brüggemann et al.
BLOOD (2006)
Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993
JM Rowe et al.
BLOOD (2005)
Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia
AA Ferrando et al.
LANCET (2004)
Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia
AP Weng et al.
SCIENCE (2004)
Comparative analysis of T-cell receptor gene rearrangements at diagnosis and relapse of T-cell acute lymphoblastic leukemia (T-ALL) shows high stability of clonal markers for monitoring of minimal residual disease and reveals the occurrence of second T-ALL
T Szczepanski et al.
LEUKEMIA (2003)
Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor B-ALL
MJ Willemse et al.
BLOOD (2002)
Share Paper
